With fish oil pill US NDA submitted, Amarin could be acquisition target
28 September 2011
Donna Young
Please Login to read the full article.
28 September 2011
Donna Young
donna.young@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Amarin rises on US FDA acceptance of fish oil pill NDA
- Omthera trials fish oil pill Epanova with statins, hoping for 2012 filing in high TG
- Amarin secures US formulation patent for fish oil pill, fueling more talk on a pharma deal
- Omthera seeks 'best in class' status for prescription omega-3 product Epanova
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
